Can changes in estrogen make a knee feel less stable? Can birth control prevent an ACL tear—or increase the chance of a knee injury? These questions matter to athletes, people with recurring sprains, and women whose joint symptoms change around their periods or menopause.
At Caring Medical, we consider ligament support an important part of understanding joint pain. However, a hormonal explanation should not replace an examination of the painful joint. A person can have pain without ligament instability, and measurable ligament looseness does not necessarily mean that an injury will occur.
The most useful distinction is between what hormones can do to connective-tissue cells, what researchers can measure in a knee, and what actually predicts injury during sport. These are related questions, but they require different kinds of evidence.

What is ligament laxity, and how does it differ from instability?
Ligaments connect bones and help guide and limit joint movement. The anterior cruciate ligament, or ACL, helps control forward movement of the shinbone relative to the thighbone and contributes to rotational stability of the knee.
Laxity describes how much movement occurs when a joint is tested. Instability describes a joint that cannot maintain adequate control during activity; a patient may describe buckling, giving way, or a lack of confidence when turning. Some people naturally have more joint movement without symptoms. Others have a specific ligament injury, muscle weakness, or movement-control difficulty that makes the joint unreliable.
These distinctions help explain why a study showing a small change in laxity cannot automatically tell us how many ACL tears will occur. Similarly, pain after exercise does not prove that a ligament has been damaged.
Our discussion of how joint instability is evaluated provides additional context. Symptoms must be interpreted alongside the examination; joint noises alone are not a diagnosis.
Newer research: Hormones affect tissue biology, but menstrual-cycle effects are less clear
A 2025 systematic review and meta-analysis included 54 studies examining sex hormones and ligament properties. Much of the research concerned the ACL and estradiol, a major form of estrogen. Laboratory findings suggested effects on collagen production, but the pooled human results did not show a menstrual-cycle effect on knee laxity or forward movement of the shinbone. The authors considered a clinically meaningful cycle-related laxity effect unlikely. (1)
This finding does not mean that a patient’s symptoms are imaginary or that hormones have no musculoskeletal effects. It means that current research does not justify assuming that normal monthly hormone changes make everyone’s ligaments dangerously loose. Tissue biology and a clinically useful injury prediction are different levels of evidence.
Is there a high-risk time in the menstrual cycle?
Estrogen and progesterone change throughout the menstrual cycle. Researchers have examined whether those changes correspond to altered balance, knee movement, ligament laxity, or ACL injury. The original studies discussed on this page remain useful, provided their actual outcomes are clear.
Balance testing at estrogen and progesterone peaks
A study published in 2024 tested 18 healthy women with regular cycles around their estrogen peak and approximately one week later around their progesterone peak. Performance on a modified Star Excursion Balance Test did not differ significantly between those testing times. (2)
The helpful finding is that balance performance was similar under the study conditions. The participants were not followed to establish equal injury rates. Therefore, the study cannot prove that ACL injury risk is identical on those days, nor can it establish safety for an individual athlete returning after injury.
Cutting movements in college soccer players
A 2023 study recruited 53 female college soccer players; 12 were excluded after screening identified anovulatory cycles or luteal-phase deficiency. Researchers assessed hormone concentrations and knee movement during a 90-degree cutting task across cycle phases. Maximum knee valgus—an inward knee angle—was lower in the mid-luteal phase. They did not find a significant correlation between measured estrogen or progesterone concentrations and knee movement parameters. (3)
These were movement measurements, not observed ACL tear rates. Lower valgus during one test does not prove that a particular phase protects an athlete. The lack of a measured correlation also does not prove that hormones have no effects under other conditions.
Why older studies reach different conclusions
An influential 2017 review found increased laxity around ovulation compared with the follicular phase and suggested possible associations between cycle timing and ACL injury. However, the authors rated the overall evidence as low strength. (4)
A 2021 paper described plans for another systematic review of knee laxity, menstrual irregularities, contraception, and noncontact ACL injuries. It was a research protocol, explaining how evidence would be assessed, rather than a completed study establishing an injury pattern. (5)
Differences in how cycle phases are identified, how hormone concentrations are measured, which athletes participate, and which outcomes are studied make comparisons difficult. A calendar estimate of ovulation is not the same as confirming hormonal changes. Results from a balance test should not be combined uncritically with results from surgical databases.
Relaxin: A possible contributor, not a proven explanation for every ACL tear
Relaxin is another hormone involved in connective-tissue remodeling. Researchers have studied its receptors in ACL tissue and whether its interactions with estrogen could influence collagen, the structural protein that helps give ligaments strength.
A 2023 systematic review included six studies, with 189 clinical participants and 51 laboratory samples. It described selective relaxin binding in ACL samples and increased expression of collagen-degrading receptors in female tissue exposed to estrogen before relaxin. Clinical observations also linked higher relaxin concentrations with ACL tears. (6)
A 2024 review likewise discussed a possible relationship between relaxin, collagen breakdown, and ACL injury in female athletes. Its authors called for further investigation. (7)
These findings offer a biological explanation worth studying. They do not show that estrogen exposure in a laboratory causes an athlete to tear her ACL. Nor do they establish a validated relaxin threshold that tells an individual whether it is safe to train.
The reviews also do not settle the question of which cycle phase carries the greatest injury risk. Conflicting phase-specific findings should remain visible rather than being reduced to a universal rule about avoiding sport at a certain time of the month.
Do oral contraceptives protect the ACL?
The older literature generated understandable interest in this question. The 2017 review suggested that oral contraceptives might be associated with a reduction in ACL injury risk, potentially around 20%, while emphasizing low-strength evidence. That estimate should not be presented as a proven preventive benefit. (4)
Important 2026 update
A 2026 review included 10 observational studies. Its primary adjusted or matched analysis found no clear association between oral contraceptive use and ACL reconstruction or surgically treated injury: odds ratio 0.89, with a 95% confidence interval of 0.77–1.02. Evidence certainty was very low. (8)
The interval includes no difference, and surgery is not interchangeable with all injuries. The findings do not support choosing contraception solely to prevent ACL tears. They are also not a reason to stop prescribed contraception; medication decisions require consideration of contraceptive needs, other indications, preferences, and risks. (8)
What about pain after heavy exercise?
A 2015 study compared 15 oral contraceptive users with 25 women who were not using oral contraceptives after a bout of squatting exercise. Pill users reported more pain. Their measured ACL laxity was lower, but the relative change in laxity and recovery over time did not differ significantly between groups. (9)
This small study did not count subsequent knee injuries. More pain after squatting cannot establish that contraception caused ligament damage, and a stiffer measurement is not automatically evidence of greater future injury risk. The practical lesson is to interpret exercise symptoms and joint findings directly rather than using pill use alone to classify someone as injury-prone.
A separate issue: Hormonal contraception and kneecap instability
The patella, or kneecap, has a different stability system from the ACL. It is important to preserve this distinction when discussing hormone research.
A 2023 database study examined reconstruction procedures for patellar instability in women aged 15–26. After matching, reconstruction occurred in approximately 0.054% of women prescribed an ethinyl-estradiol-containing contraceptive versus 0.043% of controls. For etonogestrel-only prescriptions, the corresponding figures were 0.058% and 0.026%. (10)
These are associations with an uncommon surgical outcome in the database, not proof that the medications damaged the supporting ligaments. Prescription records cannot fully capture medication use, sporting exposure, underlying anatomy, or all reasons a patient proceeds to surgery. This study should neither be relabeled as an ACL study nor used alone to advise medication changes.
Pregnancy, menopause, and broader joint symptoms
Monthly cycling, pregnancy, and menopause are different hormonal situations. The 2025 review also identified evidence that pregnancy, oral contraceptive use, and menopause may affect ligament properties beyond the ACL, including pelvic and hip ligaments. The evidence does not establish one treatment for all hormone-associated joint symptoms. (1)
For a person with pelvic pain during or after pregnancy, childbirth injury, muscle dysfunction, joint loading, and other causes need consideration. Our separate article on pelvic girdle and pelvic floor problems following childbirth addresses that clinical situation in more detail.
For someone developing knee pain around menopause, the possibilities also include osteoarthritis, a meniscus problem, tendon pain, changes in muscle function, or an old injury becoming symptomatic. The companion article on knee pain in menopausal and postmenopausal women addresses these different presentations.
Hormone replacement is a separate treatment decision. Our hormones and degenerative joint disease article discusses the broader topic. Neither a painful joint nor a feeling of looseness, by itself, demonstrates a hormone deficiency or establishes that hormone therapy will repair a ligament.
What should be evaluated when a knee feels loose or repeatedly gives way?
The history helps distinguish a new injury from recurring symptoms. Relevant details include a twisting event, a pop, swelling, locking, true buckling, previous surgery, sport demands, medication use, and whether symptoms follow a repeatable menstrual pattern.
An examination may assess ligament stability, kneecap tracking, muscle strength, movement control, and signs of meniscal or other joint injury. Imaging can help answer structural questions when indicated. A normal scan does not explain every symptom, but an abnormal scan also needs to be matched to the clinical problem.
A symptom record can help a patient describe patterns in pain, swelling, training, and menstruation. It cannot diagnose a torn ligament or prove hormonal causation. A single hormone test likewise cannot establish why a knee is giving way.
Seek prompt assessment after a significant injury with rapid swelling, inability to bear weight, or a locked knee. A hot, red, swollen joint accompanied by fever requires urgent evaluation. Persistent buckling deserves assessment because continuing to pivot on an unreliable knee can create additional risk.
What can help reduce ACL injury risk?
Research on prevention should be separated from research on hormone associations. A 2026 systematic review and meta-analysis supports neuromuscular training programs for reducing ACL rupture risk in athletes. These programs address movement control through combinations of exercises such as strength, balance, jumping, landing, and agility work. (11)
Prevention does not eliminate risk, and an exercise program for an uninjured athlete is different from rehabilitation after a tear. Return-to-sport decisions should reflect the injury, recovery, strength, and functional demands rather than presumed low-risk days of the cycle.
Where do Prolotherapy and PRP fit?
At Caring Medical, our interest in ligament support is relevant when pain accompanies a specific ligament problem or symptomatic instability. Hormone research, however, does not establish that every woman with knee pain needs ligament injections.
Dextrose Prolotherapy is an injection treatment studied for several musculoskeletal pain conditions. A systematic review described encouraging findings across some conditions, but the underlying studies varied substantially in diagnosis, design, and treatment methods. That literature does not establish that Prolotherapy reverses hormone-related ligament changes or prevents ACL tears during menstrual cycling. (12)
PRP, or platelet-rich plasma, uses a preparation from the patient’s blood. Whether PRP or Prolotherapy is relevant depends on the actual tissue problem and the evidence for that indication. The hormone studies discussed here do not test the combination and cannot establish that combining the treatments improves hormone-associated laxity.
An acute complete ACL rupture, a partial injury, kneecap instability, and chronic pain after reconstruction are different problems. Injections should not be described as a proven substitute for reconstruction in every unstable knee or as permission for an early return to pivoting sport. Injection procedures also carry risks, including pain, bleeding, infection, and injury to nearby structures.
For a more detailed discussion of the treatment decision, see ACL tears: surgery and nonsurgical options. If surgery has already occurred, our separate article addresses persistent instability and other problems after ACL reconstruction.
What this means for patients
Hormones are one part of a complex discussion about connective tissue and injury. Current evidence does not support a universal menstrual-cycle danger window or choosing contraception solely to prevent an ACL tear. Recurring joint symptoms still deserve attention, whether or not they follow a monthly pattern.
Our emphasis is on identifying the painful structure and distinguishing normal flexibility from symptomatic instability. A hormone-related theory should help frame questions, not take the place of diagnosing the actual knee problem.
This article provides general educational information and does not diagnose a condition or replace medical advice. Medication changes, injury treatment, and return-to-sport decisions require an appropriate clinical assessment.
References
1 Gilmer G, Crasta N, Tanaka MJ. The Effect of Sex Hormones on Joint Ligament Properties: A Systematic Review and Meta-analysis. The American journal of sports medicine. 2025;53(11):2738-2748. doi:10.1177/03635465241310145. [Google Scholar]
2 Baghban Baghdadabad M, Mohaghegh S. Balance test results in different hormonal statuses of the menstruation cycle. Are females more susceptible to lower extremities injuries on different days of their menstruation cycles?. Physical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine. 2024;65:54-58. doi:10.1016/j.ptsp.2023.11.003. [Google Scholar]
3 Bingzheng Z, Xinzhuo Z, Zhuo J, Xing Y, Bin L, Lunhao B. The effects of sex hormones during the menstrual cycle on knee kinematics. Frontiers in bioengineering and biotechnology. 2023;11:1209652. doi:10.3389/fbioe.2023.1209652. [Google Scholar]
4 Herzberg SD, Motu’apuaka ML, Lambert W, Fu R, Brady J, Guise JM. The Effect of Menstrual Cycle and Contraceptives on ACL Injuries and Laxity: A Systematic Review and Meta-analysis. Orthopaedic journal of sports medicine. 2017;5(7):2325967117718781. doi:10.1177/2325967117718781. [Google Scholar]
5 Nédélec E, Foli E, Shultz SJ, Swinton PA, Dolan E, Enright K, Piasecki J, Matthews JJ, Sale C, Elliott-Sale KJ. Effect of menstrual cycle phase, menstrual irregularities and hormonal contraceptive use on anterior knee laxity and non-contact anterior cruciate ligament injury occurrence in women: a protocol for a systematic review and meta-analysis. BMJ open sport & exercise medicine. 2021;7(4):e001170. doi:10.1136/bmjsem-2021-001170. [Google Scholar]
6 Berger GK, Rockov ZA, Byrne C, Trentacosta NE, Stone MA. The role of relaxin in anterior cruciate ligament injuries: a systematic review. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie. 2023;33(8):3319-3326. doi:10.1007/s00590-023-03618-7. [Google Scholar]
7 Parker EA, Duchman KR, Meyer AM, Wolf BR, Westermann RW. Menstrual Cycle Hormone Relaxin and ACL Injuries in Female Athletes: A Systematic Review. The Iowa orthopaedic journal. 2024;44(1):113-123. [Google Scholar]
8 Kobayashi EN, Silva NZ, de Azevedo LAC, de Abreu MEC, Malpaga JMD, de Oliveira DE, Jorge PB. Oral contraceptive use and anterior cruciate ligament injury or reconstruction in women: A systematic review and meta-analysis of very low-certainty evidence. Journal of experimental orthopaedics. 2026;13(4):e70940. doi:10.1002/jeo2.70940. [Google Scholar]
9 Lee H, Petrofsky JS, Yim J. Do Oral Contraceptives Alter Knee Ligament Damage with Heavy Exercise?. The Tohoku journal of experimental medicine. 2015;237(1):51-56. doi:10.1620/tjem.237.51. [Google Scholar]
10 Martinazzi BJ, Bertha N, Nam HH, Lorenz FJ, Bonaddio V, Ptasinski A, Gallo RA. Association of Systemic Hormonal Contraceptives With Reconstruction Procedures for Patellar Instability. Orthopaedic journal of sports medicine. 2023;11(10):23259671231191786. doi:10.1177/23259671231191786. [Google Scholar]
11 Watson SL, Gohal C, Owen MM, Bajaj PM, Plantz MA, Tjong VK. A Systematic Review and Meta-analysis of Anterior Cruciate Ligament Injury Prevention Programs: Training to Stay in the Game. The American journal of sports medicine. 2026;54(3):733-740. doi:10.1177/03635465251376670. [Google Scholar]
12 Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clinical medicine insights. Arthritis and musculoskeletal disorders. 2016;9:139-159. doi:10.4137/cmamd.s39160. [Google Scholar]
British, American, and Brazilian researchers writing in October 2021 in the BMJ Open Sport & Exercise Medicine (4) announced a new study to understand hormones: “Exercising women report three to six times more ACL tears than men, which happen, in the majority of cases, with a non-contact mechanism. This sex disparity has, in part, been attributed to the differences in reproductive hormone profiles between men and women. Many studies have shown that anterior knee laxity and the rate of non-contact ACL injuries vary across the menstrual cycle, but these data are inconsistent. Similarly, several studies have investigated the potential protective effect of hormonal contraceptives on non-contact ACL injuries, but their conclusions are also variable.”
A September 2023 paper in the journal Frontiers in Bioengineering and Biotechnology (5) investigated the effects of the menstrual cycle and serum sex hormone concentrations on knee kinematic parameters of the 90°cutting in female college soccer athletes. Three female college soccer teams (53 subjects) participated in the study.
- The subjects’ menstrual cycle was divided into the menstrual phase, late-follicular phase, ovulatory phase, and mid-luteal phase (Groups 1, 2, 3, 4).
- The researchers found lower maximum knee valgus in group 4 (mid-luteal phase) compared with other groups. This meant that subjects had a lower biomechanical risk of non-contact anterior cruciate ligament (ACL) injury in the mid-luteal phase. There was no significant correlation between serum estrogen, progesterone concentration, and knee kinematic parameters. This meant that sex hormones did not have a protective effect.
The controversy continues.
ACL Injury in Women, oral contraceptives
July 2017 research in the Orthopaedic Journal of Sports Medicine, (5) led by Seattle Pacific University and Oregon Health & Science University doctors examined studies suggesting an association between hormonal fluctuations and ACL injury in women athletes.
They cite that recent studies have suggested that oral contraceptives may offer up to a 20% reduction in risk of injury. In fact, recent research on ACL injuries and the menstrual cycle has more than doubled over the past decade, permitting this type of analysis for the first time.
However, the overall strength of this evidence that oral contraceptives may offer a reduction in risk of injury is low.
BUT, it needs to be studied: “Promising potential directions for future research include long-term observational studies with ongoing hormonal assays and large interventional trials of follicular suppression, including newer hormonal methods.”
In other words – research for or against oral contraceptives’ protective or non-protective role in ACL injury can be called controversial.
Here are research highlights from a recent study by doctors at the Physical Therapy Department, College of Health Science, Gachon University published in The Tohoku Journal of Experimental Medicine. (6)
The researchers looked for an answer as to why women have a greater risk for non-contact injuries of anterior cruciate ligament (ACL) compared to men when participating in the same sports.
The study examined the difference in ACL laxity after an eccentric (resistance) exercise in the lower limbs in young healthy women between oral contraceptive pill (OCP) users and non-OCP users to see the effect of oral contraceptive pill on ACL laxity.
Forty young healthy women participated in the experiments (25 with normal menstrual cycles and 15 with taking Oral Contraceptives).
ACL laxity and a visual analog pain scale (0-10) were measured before and after squatting exercises.
- Oral contraceptive pill users had more pain than non-oral contraceptive pill users after heavy exercise.
- Health professionals working with young female adults should recognize that oral contraceptive pill users may be at higher risk for having knee injuries.
References
1 Baghdadabad MB, Mohaghegh S. Balance test results in different hormonal statuses of the menstruation cycle. Are females more susceptible to lower extremities injuries on different days of their menstruation cycles?. Physical therapy in sport. 2024 Jan 1;65:54-8. [Google Scholar]
2 Martinazzi BJ, Bertha N, Nam HH, Lorenz FJ, Bonaddio V, Ptasinski A, Gallo RA. Association of Systemic Hormonal Contraceptives With Reconstruction Procedures for Patellar Instability. Orthopaedic Journal of Sports Medicine. 2023 Oct 4;11(10):23259671231191786. [Google Scholar]
3 Berger GK, Rockov ZA, Byrne C, Trentacosta NE, Stone MA. The role of relaxin in anterior cruciate ligament injuries: a systematic review. European Journal of Orthopaedic Surgery & Traumatology. 2023 Dec;33(8):3319-26. [Google Scholar]
4 Nédélec E, Foli E, Shultz SJ, Swinton PA, Dolan E, Enright K, Piasecki J, Matthews JJ, Sale C, Elliott-Sale KJ. Effect of menstrual cycle phase, menstrual irregularities and hormonal contraceptive use on anterior knee laxity and non-contact anterior cruciate ligament injury occurrence in women: a protocol for a systematic review and meta-analysis. BMJ Open Sport & Exercise Medicine. 2021 Oct 1;7(4):e001170. [Google Scholar]
5 Bingzheng Z, Xinzhuo Z, Zhuo J, Xing Y, Bin L, Lunhao B. The effects of sex hormones during the menstrual cycle on knee kinematics. Frontiers in Bioengineering and Biotechnology. 2023;11. [Google Scholar]
6 Lee H, Petrofsky JS, Yim J. Do Oral Contraceptives Alter Knee Ligament Damage with Heavy Exercise? Tohoku J Exp Med. 2015;237(1):51-6. doi: 10.1620/tjem.237.51. [Google Scholar]